Copanlisib in Combination With Venetoclax in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.
Clinical trial NCT03886649 · TERMINATED
Trial details
- NCT number
- NCT03886649
- Sponsor
- Swiss Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-04
- Primary completion
- 2021-05-10
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.